Cargando…

Prospective Single Arm Study on the Effect of Ilaprazole in Patients with Heartburn but No Reflux Esophagitis

PURPOSE: Patients with gastroesophageal reflux disease without esophagitis show varying responses to proton pump inhibitors (PPIs). The aim of this study was to objectively evaluate the effect of a new PPI, ilaprazole, on patients with heartburn but without reflux esophagitis. MATERIALS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, In Ji, Kim, Hyun Ki, Lee, Na Keum, Lee, Sang Kil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127432/ https://www.ncbi.nlm.nih.gov/pubmed/30187702 http://dx.doi.org/10.3349/ymj.2018.59.8.951

Ejemplares similares

Esophageal Acidification During Nocturnal Acid-breakthrough with Ilaprazole Versus Omeprazole in Gastroesophageal Reflux Disease
por: Karyampudi, Arun, et al.
Publicado: (2017)

Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease
por: Gold, Benjamin D., et al.
Publicado: (2017)

Comparison of Esophageal Function Tests in Chinese Patients with Functional Heartburn and Reflux Hypersensitivity
por: Gao, Feng, et al.
Publicado: (2017)

Effects of Tegoprazan Versus Esomeprazole on Nighttime Heartburn and Sleep Quality in Gastroesophageal Reflux Disease: A Multicenter Double-blind Randomized Controlled Trial
por: Kim, Joon Sung, et al.
Publicado: (2023)

Responsiveness of measures of heartburn improvement in non-erosive reflux disease
por: Junghard, Ola, et al.
Publicado: (2007)

Juice Test for Identification of Nonerosive Reflux Disease in Heartburn Patients
por: Fernandes, Michel R, et al.
Publicado: (2018)

Ilaprazole and Clopidogrel Resistance in Acute Stroke Patients
por: Lim, In Hwan, et al.
Publicado: (2022)

EsReflux Protocol: Epidemiological Study of Heartburn and Reflux-like Symptoms in Spanish Community Pharmacies
por: López-Pintor, Elsa, et al.
Publicado: (2022)

Distinction between patients with non-erosive reflux disease and functional heartburn
por: Giacchino, Maria, et al.
Publicado: (2013)

Dental evaluation is helpful in the differentiation of functional heartburn and gastroesophageal reflux disease
por: Helle, Krisztina, et al.
Publicado: (2023)

The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori
por: Lee, Seung Woo, et al.
Publicado: (2020)

Is There a Way to Differentiate Esophageal Motility Disorders in Patients With Heartburn?
por: Kim, Sung Eun
Publicado: (2021)

Clinical Characteristics of Esophageal Motility Disorders in Patients With Heartburn
por: Takahashi, Satsuki, et al.
Publicado: (2021)

Eosinophilic esophagitis prevalence in adults with dysphagia or heartburn: preliminary results
por: Boechat, Jose Laerte, et al.
Publicado: (2015)

Esophageal Epithelial-Derived IL-33 Is Upregulated in Patients with Heartburn
por: Sei, Hiroo, et al.
Publicado: (2016)

Role of Esophageal Mean Nocturnal Baseline Impedance and Post-reflux Swallow-induced Peristaltic Wave Index in Discriminating Chinese Patients With Heartburn
por: Sun, Ya Mei, et al.
Publicado: (2019)

Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori
por: Niu, Min, et al.
Publicado: (2022)

A More In-depth Evaluation of Impedance-pH Could Assist in Distinguishing Reflux-related From Reflux-unrelated Heartburn
por: de Bortoli, Nicola, et al.
Publicado: (2015)

Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease
por: Orlando, Roy C, et al.
Publicado: (2010)

Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease
por: Savarino, E, et al.
Publicado: (2009)

Correction: Esophageal Epithelial-Derived IL-33 Is Upregulated in Patients with Heartburn
por: Sei, Hiroo, et al.
Publicado: (2016)

Endoscopic-Guided Measurement of Mucosal Admittance can Discriminate Gastroesophageal Reflux Disease from Functional Heartburn
por: Matsumura, Tomoaki, et al.
Publicado: (2017)

Factors associated with dental erosions in gastroesophageal reflux disease: a cross-sectional study in patients with heartburn
por: Picos, Andrei, et al.
Publicado: (2020)

Effect of Helicobacter pylori Eradication on the Development of Reflux Esophagitis and Gastroesophageal Reflux Symptoms: A Nationwide Multi-Center Prospective Study
por: Kim, Nayoung, et al.
Publicado: (2011)

Revisiting the Role of Esophageal Mucosal Dilated Intercellular Spaces in the Diagnosis and Pathophysiology of Heartburn
por: Gorgulu, Volkan, et al.
Publicado: (2023)

Treatment of non-erosive reflux disease and dynamics of the esophageal microbiome: a prospective multicenter study
por: Park, Chan Hyuk, et al.
Publicado: (2020)

Reflux Esophagitis and Fatigue: Are They Related?
por: Kang, Sung-Goo, et al.
Publicado: (2021)

Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy
por: Strugala, Vicki, et al.
Publicado: (2012)

Improved motility in the gastrointestinal tract of a postoperative ileus rat model with ilaprazole
por: Kim, Geon Min, et al.
Publicado: (2021)

The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori: Erratum
Publicado: (2021)

Efficacy and safety of high-dose ilaprazole-amoxicillin dual therapy for Helicobacter pylori eradication: a prospective, single-center, randomized trial
por: Cheng, Jianping, et al.
Publicado: (2023)

Effect of Helicobacter pylori eradication on reflux esophagitis and GERD symptoms after endoscopic resection of gastric neoplasm: a single-center prospective study
por: Na, Hee Kyong, et al.
Publicado: (2020)

Efficacy and Safety of the Triple Therapy Containing Ilaprazole, Levofloxacin, and Amoxicillin as First-Line Treatment in Helicobacter pylori Infections
por: Ahn, Hyo Jun, et al.
Publicado: (2017)

Liq. Magnesiæ—A Remedy for Cardialgia (Heartburn.)
Publicado: (1872)

Berberine protects against esophageal mucosal damage in reflux esophagitis by suppressing proinflammatory cytokines
por: CHOO, BYUNG KIL, et al.
Publicado: (2013)

Significance of Non-erosive Minimal Esophageal Lesions in Gastro-esophageal Reflux Disorder
por: Hong, Sung-Pyo, et al.
Publicado: (2004)

Efficacy of Aceclofenac and Ilaprazole Combination Therapy versus Celecoxib Monotherapy for Treating NSAID-Induced Dyspepsia in Lumbar Spinal Stenosis Patients
por: Lee, Sanghoon, et al.
Publicado: (2023)

Therapeutic Effect of Multilevel Surgery on Laryngopharyngeal Reflux in Obstructive Sleep Apnea Patients: Impact on the Reflux Symptom Index and Reflux Finding Score
por: Song, Bokhyun, et al.
Publicado: (2022)

High Dose Ilaprazole/Amoxicillin as First-Line Regimen for Helicobacter pylori Infection in Korea
por: Kwack, WonGun, et al.
Publicado: (2016)

The Relationship of the Post-reflux Swallow-induced Peristaltic Wave Index and Esophageal Baseline Impedance with Gastroesophageal Reflux Disease Symptoms
por: Cho, Young Kyu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_27ec46kl286mpk6c5getu03ah0